LeMaitre Vascular, Inc. $LMAT Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 36.2% in the third quarter, HoldingsChannel.com reports. The fund owned 102,571 shares of the medical instruments supplier’s stock after buying an additional 27,270 shares during the quarter. ProShare Advisors LLC’s holdings in LeMaitre Vascular were worth $8,471,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Sound Income Strategies LLC increased its holdings in LeMaitre Vascular by 425.6% during the 1st quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 183 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new position in LeMaitre Vascular in the first quarter worth $32,000. Sterling Capital Management LLC grew its holdings in shares of LeMaitre Vascular by 844.2% during the third quarter. Sterling Capital Management LLC now owns 727 shares of the medical instruments supplier’s stock worth $60,000 after purchasing an additional 650 shares during the last quarter. Nykredit A S bought a new stake in shares of LeMaitre Vascular during the second quarter worth $82,000. Finally, Northwestern Mutual Wealth Management Co. bought a new stake in shares of LeMaitre Vascular during the second quarter worth $102,000. Institutional investors own 84.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on LMAT. Wells Fargo & Company reduced their price target on shares of LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 5th. Wall Street Zen cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Citigroup reaffirmed a “market outperform” rating on shares of LeMaitre Vascular in a research note on Tuesday, July 21st. Barrington Research lowered shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 5th. Finally, Weiss Ratings cut shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $110.60.

LeMaitre Vascular Price Performance

Shares of LMAT opened at $87.92 on Thursday. The stock has a market cap of $2.01 billion, a P/E ratio of 30.85, a price-to-earnings-growth ratio of 2.32 and a beta of 0.51. LeMaitre Vascular, Inc. has a 1 year low of $78.22 and a 1 year high of $118.01. The stock’s 50-day moving average price is $81.38 and its two-hundred day moving average price is $94.16. The company has a current ratio of 16.31, a quick ratio of 13.96 and a debt-to-equity ratio of 0.40.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings results on Wednesday, November 4th. The medical instruments supplier reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). LeMaitre Vascular had a net margin of 25.02% and a return on equity of 15.63%. The firm had revenue of $67.97 million during the quarter, compared to analyst estimates of $67.39 million. During the same quarter in the prior year, the business earned $0.75 earnings per share. The business’s revenue was up 11.3% on a year-over-year basis. On average, equities analysts predict that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current year.

LeMaitre Vascular Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 3rd. Shareholders of record on Thursday, November 19th will be issued a $0.25 dividend. The ex-dividend date is Thursday, November 19th. This represents a $1.00 annualized dividend and a yield of 1.1%. LeMaitre Vascular’s dividend payout ratio (DPR) is 35.09%.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a medical device company focused on the treatment of peripheral vascular disease. The company develops, manufactures and markets products used primarily by vascular surgeons and other specialists in open vascular surgery procedures.

Its product portfolio includes biological and synthetic vascular grafts, carotid shunts, embolectomy and thrombectomy catheters, valvulotomes, vessel closure devices, vascular patches and surgical instruments. These products are designed to support procedures involving the arteries and veins, including the repair, reconstruction and treatment of diseased or obstructed blood vessels.

Founded in 1983 and headquartered in Burlington, Massachusetts, LeMaitre Vascular sells its products through a combination of direct sales personnel and distributors.